Fundz

Ordaōs Raises $5 Million In Seed To Accelerate Drug Design And Discovery

PRIVATEAug 25, 2022

Amount Raised

$5 Million

Round Type

Seed

New YorkBiotechnologyHealth CareArtificial Intelligence

Description

Ordaōs, a biotechnology company designing novel mini-proteins to help drug hunters deliver life-saving treatments, today announced the completion of $5M in seed financing to aid in new product development and expand partner acquisition efforts. The oversubscribed round was led by Middleland Capital's VTC Ventures with additional investments from Route 66 Ventures, Banyan Pacific Capital, IAG Capital Partners, and Citta Capital. Ordaōs is a human-enabled, machine-driven drug design company that leverages proprietary multitask meta-learning and reinforcement learning to create mini-proteins that enable targeted therapies to reduce patient suffering, improve health, and extend life.

Quick answer

Ordaos raised $5 Million in a Seed round, dated August 25, 2022. Ordaos is based in New York, New York, United States.

How much did Ordaos raise?
Ordaos raised $5 Million in a Seed round on August 25, 2022.
What does Ordaos do?
Ordaōs is a human-enabled, machine-driven drug design company.
Where is Ordaos based and how big is it?
Ordaos is based in New York, New York, United States. Fundz records about 32 employees.
Who are the decision-makers at Ordaos?
Fundz holds 1 contact at Ordaos, including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Ordaos, and when

A new round usually means Ordaos is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ordaos raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ordaos, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ordaos. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ordaos

Location

228 Park Avenue S

New York, New York, United States

About

Ordaōs is a human-enabled, machine-driven drug design company. Our miniPRO™ proteins help drug hunters deliver treatments that are safer and more effective than traditional discovery methods.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ordaos raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsUlo P., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Ordaos's next move

See what Strategic adds

Ordaos raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.